Stocks/CNP

CNP three-lens brief

Evidence-based stock research on CNP. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.

CNP · Nightly brief
Inspect

CNP moved +0.23% overnight.

  • Negative free cash flow last quarterly (-$4.95B).
  • Debt-to-equity of 215.6 — balance-sheet-heavy.

CNP closed at $43.45 (+0.23%) as of 2026-05-04. Market cap: $28.42B. P/E (trailing) 26.7. Concerns: negative free cash flow last quarterly (-$4.95B).; debt-to-equity of 215.6 — balance-sheet-heavy.. Last quarter: Revenue $2.98B, net income $316.00M, free cash flow -$4.95B.

Market ✓· Fundamentals ✓
Informational only · Not investment advice
Three-lens method

Why three lenses on CNP, not one.

A single reasoning model has blind spots it doesn’t know about. We examine CNPacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.

Read the full methodology
Embed this brief

Drop it in your newsletter or blog.

Free to embed. Updates every 6 hours. Links back to the full brief.

<iframe
  src="https://clearpathinvest.app/embed/CNP"
  width="100%" height="420" frameborder="0"
  loading="lazy"
  title="ClearPath CNP brief"></iframe>